Psychiatry

Publications

Barzman, D; Combs, J; Lin, D. 44.4 What Is the Impact of Suicide Thought Severity and Other Demographic Factors on Deciding Treatment Disposition in Adolescent Psychiatry Emergency Room Visits?. Journal of the American Academy of Child and Adolescent Psychiatry. 2021; 60.

Blank, E; Dominick, K; Shaffer, R; Erickson, C; Lamy, M. 6.19 Outcomes of Specialized Psychiatric Inpatient Crisis Intervention for Children and Adolescents With Autism Spectrum Disorder and Other Neurodevelopmental Disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2021; 60.

Budimirovic, DB; Dominick, KC; Gabis, LV; Adams, M; Adera, M; Huang, L; Ventola, P; Tartaglia, NR; Berry-Kravis, E. Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study. Frontiers in Pharmacology. 2021; 12.

Chua, JD; Bellonci, C; Sorter, MT. Treatment of Childhood Emotion Dysregulation in Inpatient and Residential Settings. Child and Adolescent Psychiatric Clinics of North America. 2021; 30:505-525.

Combs, J; Barzman, D; Hemphill, R; Osborn, A; Sorter, M; Decker, R. Lessons Learned to Building Stakeholder Engagement during the Initial Stages of Pragmatic Research Development and Implementation. Psychiatric Quarterly. 2021; 92:781-791.

Detrick, JA; Zink, C; Rosch, KS; Horn, PS; Huddleston, DA; Crocetti, D; Wu, SW; Pedapati, EV; Wassermann, EM; Mostofsky, SH; et al. Motor cortex modulation and reward in children with attention-deficit/hyperactivity disorder. Brain Communications. 2021; 3.

Dominick, KC; Andrews, HF; Kaufmann, WE; Berry-Kravis, E; Erickson, CA. Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 2021; 31:659-669.

Early, M; Doyle, CA; Wink, L; Erickson, CA; McDougle, CJ. Clomipramine. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Erickson, CA; Wink, L; McDougle, CJ. Chlorpromazine. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Quetiapine. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Serotonin Syndrome. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Nortriptyline. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Atypical Antipsychotics. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Antidepressant Medications. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Abnormal Involuntary Movement Scale. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Thioridazine. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Sertraline. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Mesoridazine. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Serotonin Reuptake Inhibitors (SRIs). Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Aripiprazole. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Alprazolam. Encyclopedia of Autism Spectrum Disorders. 2021.

Early, M; Wink, L; Erickson, CA; McDougle, CJ. Thiothixene. Encyclopedia of Autism Spectrum Disorders. 2021.

Harris, K; Lamy, M; Sorter, M; Frye, C; Terhune, L; Erickson, CA; Ruschman, G; Dominick, KC. Letter to the Editor: Chlorpromazine-Induced Skin Pigmentation in a Pediatric Patient. Journal of Child and Adolescent Psychopharmacology. 2021; 31:516-517.

Henneberry, E; Lamy, M; Dominick, KC; Erickson, CA. Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2021; 51:4370-4394.

Jenkins, M; Barrett, MC; Frey, T; Bouvay, K; Barzman, D; Kurowski, EM. Adherence with an Acute Agitation Algorithm and Subsequent Restraint Use. Psychiatric Quarterly. 2021; 92:851-862.

Klein, C; Welge, J; Blom, T; Higdon, C; Dyce, B; Fornari, V; Gashi, S; Crystal, S; Sorter, M; Correll, C; et al. 46.6 Clinician Perception of Telemedicine-Enhanced Access to Mental Health Services During COVID-19. Journal of the American Academy of Child and Adolescent Psychiatry. 2021; 60:s245-s245.

Lin, PI; Bonander, C; Harmeyer, K; Kennedy, P; Sorter, M; Osborn, A; Barzman, D. Predicting the time trend of first episodes of aggressive behaviors in pediatric psychiatric inpatient units. Journal of Psychiatric Research. 2021; 140:117-123.

Lin, PI; Srivastava, G; Beckman, L; Kim, Y; Hallerbäck, M; Barzman, D; Sorter, M; Eapen, V. A Framework-Based Approach to Assessing Mental Health Impacts of the COVID-19 Pandemic on Children and Adolescents. Frontiers in Psychiatry. 2021; 12.

Miyakoshi, M; Schmitt, LM; Erickson, CA; Sweeney, JA; Pedapati, EV. Can We Push the "Quasi-Perfect Artifact Rejection " Even Closer to Perfection?. Frontiers in Neuroinformatics. 2021; 14.

Rossow, KM; Vaughn, SE; Strawn, JR; Van Driest, SL; Ramsey, LB. The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescents. Pharmacogenomics. 2021; 22:447-450.

Rudloff, J; Wurster Ovalle, V; Barzman, D; Gonzalez-Del-Rey, J. Psychiatric Education for Pediatric Emergency Medicine Fellows: Should We be Doing More?. Pediatric Emergency Care. 2021.

Schaefer, TL; Ashworth, AA; Tiwari, D; Tomasek, MP; Parkins, EV; White, AR; Snider, A; Davenport, MH; Grainger, LM; Becker, RA; et al. GABAA Alpha 2,3 Modulation Improves Select Phenotypes in a Mouse Model of Fragile X Syndrome. Frontiers in Psychiatry. 2021; 12.

Schmitt, L; Pedapati, E; Dominick, K; Erickson, C. CLINICAL UTILITY OF OPTIMIZED FRAGILE X PROTEIN ANALYSIS. Journal of the American Academy of Child and Adolescent Psychiatry. 2021; 60.

Schott, MM; Barzman, DH; Sorter, MT; Figueroa, N. PREDICTING THE FUTURE? UNDERSTANDING AGGRESSION RATING SCALES IN ACUTE CARE SETTINGS AND HOW TO UTILIZE THIS KNOWLEDGE. Journal of the American Academy of Child and Adolescent Psychiatry. 2021; 60.

Shillington, A; Lamy, M; Vawter-Lee, M; Erickson, C; Saal, H; Comoletti, D; Abell, K. Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder?. Journal of Autism and Developmental Disorders. 2021; 51:371-376.

Smith, EG; Pedapati, EV; Liu, R; Schmitt, LM; Dominick, KC; Shaffer, RC; Sweeney, JA; Erickson, CA. Sex differences in resting EEG power in Fragile X Syndrome. Journal of Psychiatric Research. 2021; 138:89-95.

Sorter, MT. 7.8 INPATIENT AND RESIDENTIAL TREATMENT OF EMOTION DYSREGULATION AND OUTBURSTS. Journal of the American Academy of Child and Adolescent Psychiatry. 2021; 60:s135-s136.

Vaughn, SE; Strawn, JR; Poweleit, EA; Sarangdhar, M; Ramsey, LB. The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations. Journal of Personalized Medicine. 2021; 11.

Wink, LK; Reisinger, DL; Horn, P; Shaffer, RC; O'Brien, K; Schmitt, L; Dominick, KR; Pedapati, EV; Erickson, CA. Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders. 2021; 51:1392-1399.

Yurkovic, JR; Lisandrelli, G; Shaffer, RC; Dominick, KC; Pedapati, EV; Erickson, CA; Kennedy, DP; Yu, C. Using head-mounted eye tracking to examine visual and manual exploration during naturalistic toy play in children with and without autism spectrum disorder. Scientific Reports. 2021; 11.

Zhang, W; Nery, FG; Tallman, MJ; Patino, LR; Adler, CM; Strawn, JR; Fleck, DE; Barzman, DH; Sweeney, JA; Strakowski, SM; et al. Individual prediction of symptomatic converters in youth offspring of bipolar parents using proton magnetic resonance spectroscopy. European Child and Adolescent Psychiatry. 2021; 30:55-64.